Indication

Peptococcus osteomyelitis

Peptococcus osteomyelitis refers to an infection of bone tissue caused by anaerobic Gram-positive cocci traditionally classified within the genus *Peptococcus* (many species of which have been reclassified into genera such as *Peptostreptococcus*, *Finegoldia*, or *Peptoniphilus*). Read more about Peptococcus osteomyelitis

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common Peptococcus osteomyelitis therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Peptococcus osteomyelitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Peptococcus osteomyelitis.

Peptococcus osteomyelitis refers to an infection of bone tissue caused by anaerobic Gram-positive cocci traditionally classified within the genus *Peptococcus* (many species of which have been reclassified into genera such as *Peptostreptococcus*, *Finegoldia*, or *Peptoniphilus*).

This condition primarily affects the skeletal system, most often involving the vertebrae, pelvis, or bones of the lower extremities in individuals with risk factors such as open fractures, surgical trauma, severe peripheral vascular disease, or diabetes mellitus.

Pathophysiologically, the bacteria typically spread by direct extension from adjacent chronic soft-tissue infections or ulcers, inciting inflammatory destruction, vascular thrombosis, and osseous necrosis that manifest as localized bone pain, tenderness, swelling, and delayed wound healing.

Personalize your experience

Follow Peptococcus osteomyelitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it